BOT 0.00% 34.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-66

  1. 4,077 Posts.
    lightbulb Created with Sketch. 477
    Meeting with the FDA will be interesting. Might be set up for a replication of the PhaseII study, meaning funding would need to be obtained and a delay for the phase III
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.000(0.00%)
Mkt cap ! $615.4M
Open High Low Value Volume
34.0¢ 34.0¢ 33.5¢ $134.7K 397.8K

Buyers (Bids)

No. Vol. Price($)
4 166693 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 559400 9
View Market Depth
Last trade - 10.21am 08/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.